Skip to main content

Table 1 Clinical characteristics

From: Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management

CharacteristicValue
Total number of patients25
Age (years)
 Mean± standard deviation61± 12
 Range34–86
Gender
 Male14
 Female11
Primary tumor site
 Pancreas8
 Stomach1
 Small bowel6
 Neck1
 Thymus1
 Rectum1
 Carotid glomus1
 Adrenal glands1
 Retroperitoneum1
 Lung2
 Unknown2
Sites of metastases
 Liver18
 Lymph nodes15
 Bone11
 Lung1
 Peritoneum4
 Pancreatic bed1